Minimal oligosaccharide structures required for induction of immune responses against meningococcal immunotype L1, L2, and L3,7,9 lipopolysaccharides determined by using synthetic oligosaccharide-protein conjugates.

Lignende værker

• Preparation, characterization, and immunogenicity of meningococcal immunotype L2 and L3,7,9 phosphoethanolamine group-containing oligosaccharide-protein conjugates.
  af: Verheul, A F, et al.
  Udgivet: (1991)
• Meningococcal lipopolysaccharide (LPS)-derived oligosaccharide-protein conjugates evoke outer membrane protein- but not LPS-specific bactericidal antibodies in mice: influence of adjuvants.
  af: Verheul, A F, et al.
  Udgivet: (1993)
• Meningococcal lipopolysaccharides: virulence factor and potential vaccine component.
  af: Verheul, A F, et al.
  Udgivet: (1993)
• Development, characterization, and biological properties of meningococcal immunotype L3,7,(8),9-specific monoclonal antibodies.
  af: Verheul, A F, et al.
  Udgivet: (1994)
• Conjugation of meningococcal lipopolysaccharide R-type oligosaccharides to tetanus toxoid as route to a potential vaccine against group B Neisseria meningitidis.
  af: Jennings, H J, et al.
  Udgivet: (1984)